Critical State of "Remission-Recurrence" of Ulcerative Colitis

This study will recruit 100 patients with ulcerative colitis in remission for a 6-month non intervention follow-up observation. During the study, their conditions will be recorded truthfully, including general information, disease-related symptoms and signs, inflammatory bowel disease questionnaire, anxiety self-assessment scale, depression self-assessment scale, etc., every month. Collect blood, urine, and stool samples from patients every month for examination. Follow up for each subject until their condition recurs.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Ulcerative Colitis Colitis Colitis, Ulcerative Colonic Diseases Digestive System Diseases Gastroenteritis Gastrointestinal Diseases Inflammatory Bowel Diseases Intestinal Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

Beijing Hospital of Traditional Chinese Medicine, Capital Medical University

Dongcheng, Beijing Municipality, 100010, China

Location status: Recruiting

Location contact

Luqing Zhao, Doctor

CONTACT

[email protected]

+8601087906580

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients who meet the criteria based on the clinical characteristics of ulcerative colitis patients in the "remission recurrence" critical state, combined with clinical symptoms, are diagnosed with ulcerative colitis through imaging, endoscopy, laboratory, and histopathological examinations;
Patients with comprehensive laboratory testing indicators.

Exclusion criteria

Patients with incomplete case information records;
Patients who have not completed serological tests;
Complications including intestinal obstruction, intestinal perforation, toxic megacolon, and severe local stenosis;
Diagnosed or suspected patients with coexisting uncertain colitis, infectious or ischemic colitis;
Patients with coexisting local or systemic infections, any malignant diseases, or autoimmune diseases;
Merge primary diseases such as respiratory, circulatory, neurological, endocrine, and hematological disorders;
Individuals at risk of developing cancer;
regnant or lactating women.

Treatment and study plan

Primary outcomes

The recurrence rate of patients

Time frame: The recurrence status of patients will be recorded during the 6-month follow-up period, and the recurrence rate will be calculated after all patients have completed the follow-up. It will take about 1 year to complete the entire process

The recurrence rate of 100 follow-up patients was counted at the end of the follow-up period

Study contacts

Contact information is provided by the study sponsor or research team.

Danyan Li, Doctor

CONTACT

[email protected]

15811263607

Yun Ma, Master

CONTACT

[email protected]

13681009659

Sponsors and collaborators

Lead sponsor

Beijing Hospital of Traditional Chinese Medicine

Other

Registry information

Official study title

Research on the Biological Basis of "Disease-Syndrome-Formula" in the Critical State of "Remission-Recurrence" of Ulcerative Colitis (Joint Application A)

Acronym: CSRRUC

Important dates

Study start: 2024
Primary completion: 2025
Study completion: 2025
First posted: Nov 19, 2024
Registry last updated: Nov 19, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting